(Q34119454)

31 July 2017

1 reference

title

Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs (English)

1 reference

31 July 2017

1 reference

2

Emilio Perucca

1 reference

31 July 2017

Edoardo Spina

1

1 reference

31 July 2017

1 January 2002

1 reference

31 July 2017

1 reference

31 July 2017

43 Suppl 2

1 reference

31 July 2017

37-44

1 reference

Interactions between anticonvulsant and psychoactive drugs

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Human cytochromes P450: problems and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Steady-state plasma nortriptyline concentrations in epileptic patients [letter]

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Induction of imipramine metabolism following barbiturate administration [proceedings]

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Status epilepticus associated with the combination of valproic acid and clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Carbamazepine but not valproate induces bupropion metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Interaction between phenytoin and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Carbamazepine-viloxazine interaction in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Interaction between carbamazepine and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

An interaction between carbamazepine and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Lamotrigine toxicity secondary to sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Carbamazepine-induced changes in plasma levels of neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Increased risk of hematological side-effects in psychiatric patients treated with clozapine and carbamazepine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Factors affecting chlorpromazine plasma levels in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Inducing effect of phenobarbital on clozapine metabolism in patients with chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Potential impact of valproic acid therapy on clozapine disposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Phenothiazine-induced phenytoin intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Interactions between anticonvulsants and other commonly prescribed drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Gabapentin does not alter single-dose lithium pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

The effects of lamotrigine on the pharmacokinetics of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Pharmacokinetics of diazepam in epileptic patients and normal volunteers following intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Time-course of interaction between carbamazepine and clonazepam in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2037.X

10.1046/J.1528-1157.2002.043S2037.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11903482